Swatch says sorry for ‘slanted eyes' ad following online uproar in China
Internet users slammed the 'slanted eye' gesture made by the Asian male model as racist.
In a post on Instagram and Chinese social media platform Weibo on Saturday, Swatch acknowledged the 'recent concerns regarding the portrayal of a model' in the advert and said it had deleted the promotional material worldwide.
'We sincerely apologise for any distress or misunderstanding this may have caused,' the company wrote.
Many online were not content with the company's response and continued to call for boycotting Swatch Group brands, which include Blancpain, Longines, and Tissot.
A Weibo user with more than one million followers accused the company of 'racism against Chinese' and suggested the firm should be punished by regulators.
Advertisement
A screenshot of one of the ads on Swatch's site. The image has since been taken down.
Others accused Swatch of deliberate discrimination and urged consumers to boycott the company.
'The brand's image has collapsed. (Swatch) thinks they can just apologise and salvage everything? It's not that simple,' another user wrote.
China is one of Swatch Group's biggest markets.
But along with many other Western luxury brands, the watchmaker has struggled to maintain growth as the world's second largest economy has slowed and consumers have shifted to more affordable brands.
In July, the group reported an 11.2 per cent drop in net sales for the first six months of the year.
It said the slump was 'exclusively attributable' to sluggish demand in China.
Swatch is not the first foreign brand to face accusations of racist advertising in China.
Italian luxury fashion brand Dolce & Gabbana was heavily criticised in 2018 after it posted promotional videos showing a Chinese model awkwardly using chopsticks to eat Italian food.
In 2023, French brand Dior also sparked uproar with an advertisement showing a model pulling up the corner of her eye.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Examiner
5 hours ago
- Irish Examiner
Profits down at Novartis Ireland to €8.4m as firm ups R&D spend
Pre-tax profits at the Irish arm of Swiss-headquartered pharmaceutical giant, Novartis, last year declined by 25% to €8m as the company increased its R&D spend. New accounts filed by Novartis Ireland Ltd show that the company recorded the drop in pre-tax profits as revenues declined by 10% from €268.3m to €242.3m. Novartis Ireland is a significant employer in the healthcare industry here with over 1,000 employed in Dublin. The accounts show that revenues from the sale of goods declined from €139.86m to €137.55m while revenues from supply of business services decreased from €128.46m to €104.77m. The directors state that revenues declining in pharma products sales were due to price and volume erosion of mature products. Turnover relating to Novartis Corporate Centre (NOCC) services decreased by 18% driven primarily by the reduction in functions related to Novartis's global initiative which launched in 2022 targeting a more focused pharmaceutical offering. The company has a significant R&D arm in Ireland with numbers employed in R&D last year increasing from 224 to 270. Last year, Novartis Ireland increased the R&D spend rising from €26.4m to €34.9m and the company booked an R&D credit of €4.5m in the profit and loss account. Overall numbers employed at Novartis Ireland Ltd reduced from 1,024 to 1,010 last year and the company also employed 663 in 'general and administration', 72 in marketing, sales and distribution and five in production and supply. Staff costs last year declined from €138.8m to €123.98m that included €95.5m in wages and salaries and €4.7m in share-based payments. Directors' pay increased from €992,000 to €1.35m made up of €1.27m in emoluments and €76,000 in pension contributions. They said: 'We have combined our former Novartis Technical Operations and Customer and Technology Solutions units to create a new operations unit called operations. This new unit seeks to provide a stronger and simpler operational backbone that can accelerate multiple technology transformation initiatives more efficiently, create novel digital solutions at scale, and increase productivity, while maintaining industry-leading quality and service levels." During the year, the company launched two new medicines aimed at tackling cancer, Luxturna and Leqvio. Under the heading of patient expiration and product competition, the directors said: 'The Irish government continues to closely monitor pharmaceutical pricing and profitability, with pressure to control spending on HSE medicines.' They state that the company 'manages these risks by having a strong pipeline, ensuring that it brings innovative products to market and using competitive pricing strategies while closely monitoring costs'. Shareholder funds totalled €88.8m that included accumulated profits of €51.9m.
Irish Independent
11 hours ago
- Irish Independent
The Indo Daily: Secret messages, codewords and a phone smashed with an axe – The Irishman caught in 'biggest corporate espionage case of the century'
Earlier this year a spy trail of secret messages, codewords and a phone smashed with an axe unfolded in front of the High Court in an extraordinary tale of alleged corporate espionage. The story of Dublin man Keith O'Brien made international headlines when his employer, a major US HR services firm, set a 'trap' to identify how confidential information was being leaked – and the saga is not over yet. His 13-page confession was read to the High Court, where he told how he spied on his multinational employer for a rival for a fee of over €5,000 a month. That is, until he was caught. In an affidavit filed with the High Court, Keith O'Brien, who was global payroll compliance manager of Rippling, said he was induced into spying and passing sensitive company information to the CEO of rival US firm Deel Inc. The admission was disclosed during an application to join Deel, its French chief executive Alex Bouaziz and two solicitors working for Deel – Italian national Andrea David Mieli and UK-based Asif Malik – as co-defendants in corporate espionage proceedings taken by Rippling against Mr O'Brien last month. The Commercial Court heard Mr O'Brien passed on screenshots from Rippling's Slack messaging system to Mr Bouaziz, who was described as a billionaire, over the course of several months and was paid for this via Revolut and in cryptocurrency. Today, on the Indo Daily, Fionnán Sheahan is joined by Irish Independent legal affairs editor Shane Phelan and Sunday Independent senior correspondent Maeve Sheehan, to discuss how a payroll compliance manager was allegedly recruited as a corporate spy – and where the intrigue will go next.
RTÉ News
16 hours ago
- RTÉ News
The White House launches TikTok account
The White House launched a TikTok account, as President Donald Trump continues to permit the Chinese-owned platform to operate in the United States despite a law requiring its sale. "America we are BACK! What's up TikTok?" read a caption on the account's first post on the popular video sharing app, a 27-second clip. The new account, @whitehouse, went live yesterday evening with an initial video showing footage of Mr Trump as he declares: "I am your voice." The account had about 4,500 followers an hour after posting the video. Mr Trump's personal account on TikTok meanwhile has 110.1 million followers, though his last post was on 5 November, 2024 which was Election Day. TikTok is owned by China-based internet company ByteDance. A federal law requiring TikTok's sale or ban on national security grounds was due to take effect the day before Mr Trump's inauguration on 20 January. But the Republican, whose 2024 election campaign relied heavily on social media and who has said he is fond of TikTok, put the ban on pause. In mid-June Mr Trump extended a deadline for the popular video-sharing app by another 90 days to find a non-Chinese buyer or be banned in the US. That extension is due to expire on 17 September. While Mr Trump had long supported a ban or divestment, he reversed his position and vowed to defend the platform - which boasts almost two billion global users - after coming to believe it helped him win young voters' support in the November election. Mr Trump's official account on X, formerly Twitter, has 108.5 million followers - though his favored social media outlet is Truth Social, which he owns, where he has 10.6 million followers. The official White House accounts on X and Instagram have 2.4 million and 9.3 million followers, respectively.
